Mental health apps Headspace, Ginger to merge into $3B Headspace Health

Two acquisition prospects, Headspace and Ginger, decided to beat the heat and merge. The two companies, currently headquartered in Santa Monica and San Francisco, will combine into Headspace Health. From the context of the release, the Ginger brand will be sunsetting. The merger is expected to close in Q4 subject to the usual regulatory and financial approvals. Financial terms were not disclosed. The combined company claims a valuation of $3 billion.

Leadership will combine from both companies. Russell Glass, Ginger’s present CEO, will be CEO of Headspace Health. CeCe Morken will remain CEO of Headspace and take on the additional role of President for the combined entity. 

Digital mental health continues to be hot in a hot August. Headspace, which started as a mindfulness and meditation app in 2010, then sidled into behavioral coaching to mitigate stress and aid in sleep, to date raised $216 million through a Series C (Crunchbase). Ginger, a cognitive therapy service with both self-guided coaching and psychiatric video consults, was founded in 2011 and raised $220 million through a Series E. Headspace has a direct to consumer focus with business partnerships with Google, Roche, and employers, while Ginger has developed into a benefit for payers like Cigna and Amerihealth Caritas. The combined company claims it will cover 100 million lives direct-to-consumer and through its more than 2,700 employers and health plan partners.

It is obvious from the management setup and the overpadded release (sorry, but it’s true!) that the lead company in this is Headspace. Can an IPO be far away? Release, Healthcare Dive

Symptom checker K Health gains $48 million Series C (NY/Tel Aviv)

While we’re on the subject of symptom checkers (Babylon Health below), K Health, a competitor in the US HQ’d in NYC, but also based in Tel Aviv, announced today their win of $48 million in a Series C funding round, led by 14W and Mangrove Capital Partners. Lerer Hippeau, Anthem (also a partner), Primary Ventures, and others participated. Their total funding is $97 million since November 2016. The new funding, according to Crunchbase News, will be used to scale the model, expand primary care to mobile devices, and expand to international markets. 

K (as they call themselves) concentrates on three areas. One is an AI-powered symptom checker that uses millions (they state) of anonymized medical records to provide a virtual consult. According to Crunchbase, the medical records came from Israel’s second-largest HMO, Maccabi, over 20 years. The app questions the user based on previous answers. K contrasts it to static protocols, or rules-based symptom checking. The second is to provide a primary care visit via text for $19/visit (or unlimited for $39/year) with free follow-ups over two weeks. The third is mental health, specifically treatment for anxiety and depression, a growing area both online and via mobile. The $29/month fee covers unlimited doctor visits and delivered prescription medication, excepting meds that require blood testing.

The symptom checker is available throughout the US and primary care in 47 states. According to Crunchbase’s interview with CEO Allon Bloch, they recently passed their 3 millionth user and are now available in Spanish. The company has grown in the past year from 80 to 200 people. Originally, the company linked to New York-based providers, but moved away from that to the primary care/text model. Their overall goal is to provide affordable diagnoses that are a lot more accurate than ‘Dr. Google’ and that steer the patient to the right care.

Should Babylon Health be serious about expansion to the US, they will be running up against K Health, as well as competitors such as 98point6. In the hybrid app-and-physical model, there are Carbon Health and One Medical. Also Mobihealthnews 

Launches: MyHealthApps directory, mobile mental health app in Cambridgeshire

MyHealthApps launches; Sun Network launches Crisis Card app for Cambridgeshire residents

Last year at this time, the PatientView patient research firm published The European Directory of Health Apps 2012-2013 with about 200 entries. Alex Wyke from PatientView has been kind enough to follow up and let us know as a comment on the original article [TTA 15 Nov 2012] that it has been expanded and relaunched as MyHealthApps. The site has grown to 307 apps selected by over 450 patient groups and with ‘heart’ ratings on a five-point system. While not comprehensive yet, notably it is now a truly international website with mirror sites in 48 languages from Albanian to Welsh, including four varieties of English (!) There are also submission links for patient groups and developers. PatientView developed this with support from: GSK, Janssen, Novo Nordisk, O2/Telefonica Europe, Vodafone Foundation, NHS England’s Library of Health Apps, UK government body KTN CONNECT and the European Commission’s Directorate General for Communications Networks, Content and Technology (DG CONNECT). The patient group review and backing (more…)